Yuki Hasegawa

Director/Miembro de la Junta en NANO MRNA CO.,LTD. .

46 años

Health Technology

Finance

Technology Services

Perfil

Yuki Hasegawa currently works at ActualEyes, Inc., as Director, NANO MRNA Co., Ltd., as Outside Director from 2021, and Whiz Partners, Inc., as Head-Healthcare Investment from 2021.

Cargos activos de Yuki Hasegawa

Empresas	Cargo	Inicio
NANO MRNA CO.,LTD.	Director/Miembro de la Junta	01/06/2021
Whiz Partners, Inc. Whiz Partners, Inc. Investment ManagersFinance Whiz Partners, Inc. (Whiz Partners) is an independent venture capital firm headquartered in Tokyo, Japan. It became a separate entity from its former brand, CSK Venture Capital Co., Ltd. The firm was founded by Toshio Ando, Atsushi Matsumura, and Junichi Kajimoto in 2010.	Inversor de Capital Privado	01/01/2021
ActualEyes, Inc. ActualEyes, Inc. Packaged SoftwareTechnology Services ActualEyes, Inc. is a Japanese company that conducts research and development of products such as regenerative medicine for corneal endothelial disease. The company is based in Kyotanabe, Japan. The company's mission is to deliver the desired light to patients suffering from visual impairment and to ensure and promptly implement a new treatment society. The company was founded in 2018. The CEO is Iku Sugioka.	Director/Miembro de la Junta	-

Todos los cargos activos de Yuki Hasegawa

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Yuki Hasegawa.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
NANO MRNA CO.,LTD.	Health Technology

Empresas privadas	2
Whiz Partners, Inc. Whiz Partners, Inc. Investment ManagersFinance Whiz Partners, Inc. (Whiz Partners) is an independent venture capital firm headquartered in Tokyo, Japan. It became a separate entity from its former brand, CSK Venture Capital Co., Ltd. The firm was founded by Toshio Ando, Atsushi Matsumura, and Junichi Kajimoto in 2010.	Finance
ActualEyes, Inc. ActualEyes, Inc. Packaged SoftwareTechnology Services ActualEyes, Inc. is a Japanese company that conducts research and development of products such as regenerative medicine for corneal endothelial disease. The company is based in Kyotanabe, Japan. The company's mission is to deliver the desired light to patients suffering from visual impairment and to ensure and promptly implement a new treatment society. The company was founded in 2018. The CEO is Iku Sugioka.	Technology Services